Registration, storage and distribution of chemicals and drugs for pre-clinical discovery, evaluation and development
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N91023D00002
- Awardee
-
Fisher Bioservices Inc. UEI LB4PCGLSJ9E6 Part of Thermo Electron Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $11,924,311 obligated
Award facts
- Opportunity
-
- Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development Pre-Solicitation · NCIDCTD230001 · Posted Oct 6, 2021
- Combined order value
-
- $12,174,124 Current, with exercised options
- $15,274,284 Potential, with all options
- Last date to order 73% complete
- IDV ceiling 63% used
- $18,999,981.00
- Maximum order
- $18,999,981.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- S215 Housekeeping- Warehousing/Storage
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Cancer Institute (NCI) awarded a $19 million single-award Indefinite Delivery Contract (IDC) to Fisher Bioservices Inc., a subsidiary of Thermo Electron Corporation, for the registration, storage, and distribution of chemicals and drugs to support preclinical discovery, evaluation, and development. This unrestricted contract has a base period of 1 year and a total potential value of $19 million over the 5-year ordering period ending in 2028.
The contract requires Fisher Bioservices to operate and maintain the NCI's Chemotherapeutic Agents Repository, handling hundreds of thousands of individual samples. This includes providing an informational interface with NCI and external investigators, updating the chemical database, systematic record-keeping, and sample reacquisition and distribution services. Fisher Bioservices has extensive experience as both a prime contractor and subcontractor for federal agencies, supporting biomedical research and public health initiatives through specialized biorepository and materials management services.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N91023D00002?
75N91023D00002 was awarded to Fisher Bioservices Inc. by National Cancer Institute (National Institutes of Health) on March 1, 2023.
How much is contract 75N91023D00002 worth?
Orders under 75N91023D00002 have obligated $11,924,311. Their combined current value, with exercised options, is $12,174,124. Their combined potential value, with all options, is $15,274,284. 75N91023D00002's own ceiling is $18,999,981. A single order can be worth up to $18,999,981.
How many orders have been placed under contract 75N91023D00002?
2 orders have been placed under 75N91023D00002, the latest on April 1, 2023.
Who can order from contract 75N91023D00002?
75N91023D00002 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N91023D00002 competed?
The extent of competition for 75N91023D00002 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV